Document is current
Any future updates will be listed below
-
Authors
Blue, Steven M. https://orcid.org/0000-0003-0279-6690
Yee, Brian A.
Pratt, Gabriel A.
Mueller, Jasmine R.
Park, Samuel S. https://orcid.org/0000-0002-9230-7661
Shishkin, Alexander A.
Starner, Anne C.
Van Nostrand, Eric L. https://orcid.org/0000-0002-5188-0082
Yeo, Gene W. https://orcid.org/0000-0002-0799-6037
-
Funding
Funding for this research was provided by:
U.S. Department of Health & Human Services | National Institutes of Health (HG009889, HG004659, HG009889, HG004659, HG009889, HG004659, HG009889, HG004659, HG009889, HG004659, HG009889, HG004659, HG009530)
- License Information
-
More Information
Article History
Received: 28 April 2021
Accepted: 15 December 2021
First Online: 23 March 2022
Competing interests
: G.W.Y. is co-founder, member of the Board of Directors, on the Science Advisory Board, an equity holder and a paid consultant for Locanabio and Eclipse BioInnovations. G.W.Y. is a visiting professor at the National University of Singapore. G.W.Y.’s interest(s) have been reviewed and approved by the University of California, San Diego in accordance with its conflict-of-interest policies. A.A.S. is co-founder and Research & Development Director for Eclipse Bioinnovations. E.L.V.N. is co-founder, member of the Board of Directors, on the Science Advisory Board, an equity holder and a paid consultant for Eclipse BioInnovations. E.L.V.N.’s interest(s) have been reviewed and approved by Baylor College of Medicine in accordance with its conflict-of-interest policies. The authors declare no other competing interests.
